Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00689273 · ClinicalTrials.gov registry record · Phase 2
Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study In Subjects With Osteoarthritic Pain Of The Knee
A Phase 2 study, sponsored by Pfizer.
- Completed
- Registry status
- Phase 2
- Development phase
- 159
- Enrollment target
NCT00689273 is a Phase 2 study that has completed, run by Pfizer. The registered enrollment target is 159 participants.
The verdict
NCT00689273, a Phase 2 study, has completed, sponsored by Pfizer.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 159 participants
- Enrollment target
Study Summary
To evaluate the efficacy, safety, tolerability, pharmacodynamics, and pharmacokinetics in patients with osteoarthritic pain of the knee. The most painful knee joint will be identified as the index joint at screening, and this joint will be used for all pain assessments throughout the study.
Interventions
- DRUG Placebo
- DRUG PF-04136309
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 159 participants |
| Start Date | 2008-08-05 |
| Est. Completion | 2008-11-27 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00689273
The ClinicalTrials.gov registry entry for NCT00689273 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 159 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Pfizer, which has 1,845 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT00689273 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00689273 about?
NCT00689273 is a clinical study titled "Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study In Subjects With Osteoarthritic Pain Of The Knee". To evaluate the efficacy, safety, tolerability, pharmacodynamics, and pharmacokinetics in patients with osteoarthritic pain of the knee. The most painful knee joint will be identified as the index joint at screening, and this joint will be used for all pain assessments throughout the study.
What is the current status of trial NCT00689273?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 159 participants. The study started on 2008-08-05. Estimated completion is 2008-11-27.
What interventions are being tested in trial NCT00689273?
The interventions under investigation include: Placebo (DRUG), PF-04136309 (DRUG).
Who is sponsoring clinical trial NCT00689273?
This trial is sponsored by Pfizer, which has 1,845 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.